Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016;6(1):3-8.
doi: 10.15171/bi.2016.01. Epub 2016 Mar 28.

Sulfasalazine-induced renal and hepatic injury in rats and the protective role of taurine

Reza Heidari  1 , Maryam Rasti  2 , Babak Shirazi Yeganeh  3 , Hossein Niknahad  4 , Arastoo Saeedi  2 , Asma Najibi  4
Affiliations

Sulfasalazine-induced renal and hepatic injury in rats and the protective role of taurine

Reza Heidari et al. Bioimpacts. 2016.

Abstract

Introduction: Sulfasalazine is a drug commonly administrated against inflammatory-based disorders. On the other hand, kidney and liver injury are serious adverse events accompanied by sulfasalazine administration. No specific therapeutic option is available against this complication. The current investigation was designed to evaluate the potential protective effects of taurine against sulfasalazine-induced kidney and liver injury in rats.

Methods: Male Sprague-Dawley rats were administered with sulfasalazine (600 mg/kg, oral) for 14 consecutive days. Animals received different doses of taurine (250, 500 and 1000 mg/ kg, i.p.) every day. Markers of organ injury were evaluated on day 15(th), 24 h after the last dose of sulfasalazine.

Results: Sulfasalazine caused renal and hepatic injury as judged by an increase in serum level of creatinine (Cr), alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), and alkaline phosphatase (ALP). The levels of reactive oxygen species (ROS) and lipid peroxidation were raised in kidney and liver of sulfasalazine-treated animals. Moreover, tissue glutathione reservoirs were depleted after sulfasalazine administration. Histopathological changes of kidney and liver also endorsed organ injury. Taurine administration (250, 500 and 1000 mg/kg/day, i.p) alleviated sulfasalazine-induced renal and hepatic damage.

Conclusion: Taurine administration could serve as a potential protective agent with therapeutic capabilities against sulfasalazine adverse effects.

Keywords: Anti-rheumatoid drugs; Drug-induced liver injury; Hepatotoxicity; Renal injury; Taurine.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Fig. 2
Fig. 2
Fig. 3
Fig. 3
Fig. 4
Fig. 4
Fig. 5
Fig. 5
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Corea N. Sulfasalazine. In: Enna SJ, Bylund DB, eds. xPharm: The Comprehensive Pharmacology Reference. New York: Elsevier; 2007:1-5.
    1. Boyer DL, Li BUK, Fyda JN, Friedman RA. Sulfasalazine-induced hepatotoxicity in children with inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. 1989;8:528–532. doi: 10.1097/00005176-198905000-00018. - DOI - PubMed
    1. Jobanputra P, Amarasena R, Maggs F. Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: a case series from a local surveillance of serious adverse events. BMC Musculoskeletal Disorders. 2008;9 doi: 10.1186/1471-2474-9-48. - DOI - PMC - PubMed
    1. Lau G, Kwan C, Chong SM. The 3-week sulphasalazine syndrome strikes again. Forensic Science International. 2001;122:79–84. doi: 10.1016/S0379-0738(01)00476-5. - DOI - PubMed
    1. De Abajo FJ, Montero D, Madurga M, Rodríguez LA. Acute and clinically relevant drug-induced liver injury: a population based case-control study. British Journal of Clinical Pharmacology. 2004;58:71–80. doi: 10.1111/j.1365-2125.2004.02133.x. - DOI - PMC - PubMed

LinkOut - more resources